Exosomal miR-625-3p derived from CAFs may promote the migration and invasion of CRC cells, EMT, and chemoresistance by inhibiting the CELF2/WWOX pathway, which provides an effective strategy for the treatment of CRC. The gene discussed is CELF2; the disease is colorectal carcinoma.